|
 |
|
|
 |
.TOP NEWS
SIO Submits Recommendations to NCCN Palliative Care Panel
SIO has submitted recommendations to the NCCN Palliative Care Panel. Submitted by William Rilling, MD, FSIR; Ernesto Santos, MD; and Sean Tutton, MD, FSIR, FCIRSE alongside NCCN Guidelines Chair Amy Deipolyi, MD. This Letter requests the NCCN Palliative Care Guidelines panel review the recommendation for Interventional Radiologist (IR) on the panel in addition to a recommendation to include image-guided ablation and cementoplasty as considerations to palliate painful bone metastases. Download the complete 2022 letter here.
|
|
Learn About Research Protocols, Nuts and Bolts of an Abstract and More in SIO's Lecture Series
Join SIO for free educational lectures designed for early-career interventional radiologists, covering the basics of research development. The talks will feature a meeting style format that will allow face-to-face discussion with top experts.
- The recording for the 21 June lecture, "Essential Elements of a Research Protocol," is now available to view within IO University.
- Register here for the 28 June lecture, "Nuts and Bolts: IR, Statistics, and How to Turn an Idea for a Retrospective Review into an Abstract."
When registering for the series, developed by the SIO Research Development Subcommittee, you will be asked to submit a brief research question you'd like to explore to help make the most of your experience.
Secure your spot today to join the next generation of IO researchers!
|
|
FDA 101 for Surgical Oncologists — Intro to FDA and the Center for Biologics Evaluation and Research 
Tune into the Society of Surgical Oncology (SSO)'s all-new, complimentary webinar series for the chance to take your learning to the next level. Thanks to our ongoing partnership with the SSO, members of the SIO community have the chance to find out what the Food and Drug Administration (FDA) regulates directly from FDA faculty.
In part one of this series, taking place on Thursday, 23 June at 5 p.m. ET, participants will have the opportunity to learn about...
Please note: You must create a free SSO account online to register.
Don't Miss a Beat
On Monday, 16 May, SSO and SIO co-hosted a virtual tumor board on primary and metastatic liver cancer. If you were unable to make the live session, or want to catch up on something you missed, visit the SIO website to find a digital recording of the live session.
|
|
|
|
 |
|
Over 30 Years of Radiation Therapy Service Call or email us so we can help you provide the best possible care to your radiation therapy patients. Specializing in small therapy supplies. Marking Pens - Bolus - Thermoplastic Mask Table Pads - Skin Markers - Foam Positioners Plus many more supplies on our web site.
Phone: 1-800-326-4761 1-850-476-1078
Fax: 1-850-476-8426
|
|
Check Out Your New-and-Improved IO University
In an effort to improve your experience, SIO has upgraded its online learning center!
The new-and-improved IO University will serve as your center for all of SIO's education—from webinars to Annual Meeting recordings.
Log in to your SIO account to access our revamped IO University!
|
|
Renew Your SIO Membership Today
 SIO members and volunteers are working to move the field of IO forward in research and education to solidify IO as the fourth pillar of cancer therapy. You don't want to miss out on what SIO has in store this summer.
From member exclusive education opportunities, brand new advocacy events, and new abstract scholarship opportunities, SIO serves as the premier society for IO professionals to network and advance their practice this fall and beyond.
Renew your membership to continue accessing this network of front-running IO advocates and resources through 2022!
|
|
.INDUSTRY NEWS
Acute Kidney Injury in Adult Patients With Hepatocellular Carcinoma After TACE or Hepatectomy Treatment
Frontiers in Oncology via PubMed
Acute kidney injury (AKI) is one of the most common complications in patients with cancer, yet the specific reasons, mechanisms, and the influence of AKI are not clear in hepatocellular carcinoma (HCC) after treatment. This meta-analysis aimed to find out the risk factors and the impact on mortality of AKI in adult patients with HCC after treatment using available published data.
|
|
Improving Adjuvant Liver-Directed Treatment Recommendations for Unresectable Hepatocellular Carcinoma: An Artificial Intelligence-Based Decision-Making Tool
JCO Clinical Cancer Informatics via PubMed
Liver-directed therapy after transarterial chemoembolization (TACE) can lead to improvement in survival for selected patients with unresectable hepatocellular carcinoma (HCC). However, there is uncertainty in the appropriate application and modality of therapy in current clinical practice guidelines. The aim of this study was to develop a proof-of-concept, machine learning (ML) model for treatment recommendation in patients previously treated with TACE and select patients who might benefit from additional treatment with combination stereotactic body radiotherapy (SBRT) or radiofrequency ablation (RFA).
|
|
|
|
|
|
